Publication | Closed Access

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer

Gastrointestinal OncologyMedicineCancer ManagementPathologyGastric CancerCancer TreatmentOncologyRadiation OncologyMetastatic And/or Recurrent